Arianna Filntisi
Research Subjects
Arianna Filntisi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dimitrios Vlachakis
Choremion Laboratory, University Research Institute of Maternal and Child Health and Precision Medicine, “Aghia Sophia” Children’s Hospital, 115 27 Athens, Greece
2 shared publications George K. Matsopoulos
2 shared publications- Athanasios Anastasiou
National Technical University of Athens
1 shared publication - Dimitrios Koutsouris
National Technical University of Athens
1 shared publication - George K. Matsopoulos
Biomedical Engineering Laboratory, Institute of Communication and Computer Systems of the National Technical University of Athens, 15773 Athens, Greece
1 shared publication Sophia Kossida
Bioinformatics and Medical Informatics Team, Biomedical Research Foundation of the Academy of Athens, Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 10 June 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (12) , 5942
Exploring the Utility of Anonymized EHR Datasets in Machine Learning Experiments in the Context of the MODELHealth Project
The object of this paper was the application of machine learning to a clinical dataset that was anonymized using the Mondrian algorithm. (1) Background: The preservation of patient privacy is a necessity rising from the increasing digitization of health data; however, the effect of data anonymization on the performance of machine learning models remains to be explored. (2) Methods: The original EHR derived dataset was subjected to anonymization by applying the Mondrian algorithm for various k values and quasi identifier (QI) set attributes. The logistic regression, decision trees, k-nearest neighbors, Gaussian naive Bayes and support vector machine models were applied to the different dataset versions. (3) Results: The classifiers demonstrated different degrees of resilience to the anonymization, with the decision tree and the KNN models showing remarkably stable performance, as opposed to the Gaussian naïve Bayes model. The choice of the QI set attributes and the generalized information loss value played a more important role than the size of the QI set or the k value. (4) Conclusions: Data anonymization can reduce the performance of certain machine learning models, although the appropriate selection of classifier and parameter values can mitigate this effect.
- 10 June 2022
- Published by MDPI AG in Applied Sciences
- Vol. 12 (12) , 5942
Open AccessExploring the Utility of Anonymized EHR Datasets in Machine Learning Experiments in the Context of the MODELHealth Project
The object of this paper was the application of machine learning to a clinical dataset that was anonymized using the Mondrian algorithm. (1) Background: The preservation of patient privacy is a necessity rising from the increasing digitization of health data; however, the effect of data anonymization on the performance of machine learning models remains to be explored. (2) Methods: The original EHR derived dataset was subjected to anonymization by applying the Mondrian algorithm for various k values and quasi identifier (QI) set attributes. The logistic regression, decision trees, k-nearest neighbors, Gaussian naive Bayes and support vector machine models were applied to the different dataset versions. (3) Results: The classifiers demonstrated different degrees of resilience to the anonymization, with the decision tree and the KNN models showing remarkably stable performance, as opposed to the Gaussian naïve Bayes model. The choice of the QI set attributes and the generalized information loss value played a more important role than the size of the QI set or the k value. (4) Conclusions: Data anonymization can reduce the performance of certain machine learning models, although the appropriate selection of classifier and parameter values can mitigate this effect.
- Open Access
- 27 July 2016
- Published by IntechOpen
A Bioinformatics Method for the Production of Antibody-Drug Conjugates Through Site-Specific Cysteine Conjugation
A Bioinformatics Method for the Production of Antibody-Drug Conjugates Through Site-Specific Cysteine Conjugation | InTechOpen, Published on: 2016-07-27. Authors: Arianna Filntisi, Dimitrios Vlachakis and George K. Matsopoulos
- 27 July 2016
- Published by IntechOpen
Open AccessA Bioinformatics Method for the Production of Antibody-Drug Conjugates Through Site-Specific Cysteine Conjugation
A Bioinformatics Method for the Production of Antibody-Drug Conjugates Through Site-Specific Cysteine Conjugation | InTechOpen, Published on: 2016-07-27. Authors: Arianna Filntisi, Dimitrios Vlachakis and George K. Matsopoulos
- Open Access
- 1 January 2014
- Published by SAGE Publications in Cancer Informatics
- Vol. 13, CIN.S19222-86
Computational Construction of Antibody–Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable Linker
Antibody-drug conjugates (ADCs) constitute a category of anticancer targeted therapy that has gathered great interest during the last few years because of their potential to kill cancer cells while causing significantly fewer side effects than traditional chemotherapy. In this paper, a process of computational construction of ADCs is described, using the surface lysines of an antibody and a non-covalent linker molecule, as well as a cytotoxic substance, as files in Protein Data Bank format. Also, aspects related to the function, properties, and development of ADCs are discussed.
- 1 January 2014
- Published by SAGE Publications in Cancer Informatics
- Vol. 13, CIN.S19222-86
Open AccessComputational Construction of Antibody–Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable Linker
Antibody-drug conjugates (ADCs) constitute a category of anticancer targeted therapy that has gathered great interest during the last few years because of their potential to kill cancer cells while causing significantly fewer side effects than traditional chemotherapy. In this paper, a process of computational construction of ADCs is described, using the surface lysines of an antibody and a non-covalent linker molecule, as well as a cytotoxic substance, as files in Protein Data Bank format. Also, aspects related to the function, properties, and development of ADCs are discussed.